title: The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer.
authors.forename: A
authors.initials: A
authors.lastname: Hubert
authors.forename: T
authors.initials: T
authors.lastname: Peretz
authors.forename: O
authors.initials: O
authors.lastname: Manor
authors.forename: L
authors.initials: L
authors.lastname: Kaduri
authors.forename: N
authors.initials: N
authors.lastname: Wienberg
authors.forename: I
authors.initials: I
authors.lastname: Lerer
authors.forename: M
authors.initials: M
authors.lastname: Sagi
authors.forename: D
authors.initials: D
authors.lastname: Abeliovich
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D024682:BRCA2 Protein; D005260:Female; D018703:Founder Effect; D019398:Genes, BRCA1 / Q000235:genetics*; D005799:Genes, Dominant; D020022:Genetic Predisposition to Disease; D018095:Germ-Line Mutation / Q000235:genetics*; D006801:Humans; D007557:Israel / Q000453:epidemiology; D007585:Jews / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000235:genetics*; D017430:Prostate-Specific Antigen / Q000032:analysis; D011471:Prostatic Neoplasms / Q000453:epidemiology / Q000235:genetics* / Q000378:metabolism; D014157:Transcription Factors / Q000235:genetics*
chemical_list: D024682:BRCA2 Protein; D009363:Neoplasm Proteins; D014157:Transcription Factors; D017430:Prostate-Specific Antigen